MICHAEL GILCREASE to Mesoderm
This is a "connection" page, showing publications MICHAEL GILCREASE has written about Mesoderm.
Connection Strength
0.110
-
Inhibition of the phosphoinositide 3-kinase pathway for the treatment of patients with metastatic metaplastic breast cancer. Ann Oncol. 2015 Jul; 26(7):1346-52.
Score: 0.110